We examined the association of a novel SNP in IFG-I (IGF-I -C1245T located in the promoter) and eight SNPs in the IGF-II gene region with indicators of muscle damage (strength loss, muscle soreness, and increases in circulating levels of creatine kinase [CK] and myoglobin) after eccentric exercise. We also examined 2 SNPs in the IGF binding protein-3 (IGFBP-3). The age, height and body mass of the 151 subjects studied were 24.1 ± 5.2 yrs, 170.8 ± 9.9 cm, and 73.3 ± 17.0 kg, respectively. There were no significant associations of phenotypes with IGF
INTRODUCTION
Eccentric, muscle lengthening, contractions produce high levels of strain on muscle, resulting in damage that is manifested in prolonged losses in strength and range of motion, development of delayed onset muscle soreness, and increases in muscle proteins [e.g. creatine kinase (CK) and myoblobin (Mb)] in the circulation (7, 23, (29) (30) (31) 35) . We have found that individual responses to a standardized elbow flexion eccentric exercise are highly variable (8) . To explain this phenomenon, we examined whether polymorphisms of two proteins coding for components of the sarcomere were associated with muscle damage after eccentric exercise in a sample size of 151 men and women who performed the standard elbow flexion eccentric exercise protocol (6) .
We found an association between a polymorphism in the sarcomeric protein myosin light chain kinase (MLCK; currently abbreviated MYLK) (2 SNPs tested; C49T and C37885A) and changes in blood CK and Mb and isometric strength. Following the eccentric exercise, those subjects homozygous for the MLCK 49T rare allele had a significantly greater increase in CK and Mb compared with the heterozygotes (CT), and those heterozygous for MLCK C37885A had a significantly greater increase in CK compared with the homozygous wildtype (CC). MLCK C37885A was also associated with post-exercise strength loss; the heterozygotes demonstrated greater strength loss compared with the homozygous wild type. These results show that variations in genes coding for a specific myofibrillar protein influence the phenotypic response to muscle damaging exercise. Since variations in these genes explained less than 16% of the variation in the various phenotype measures, other genetic factors must contribute to this variability as well.
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It is well known that muscles increase in size in response to a resistance exercise program, and the stimulus for hypertrophy is considered to be muscle damage, likely from eccentric contractions (12) . We therefore considered whether polymorphisms in genes that are involved in muscle growth, specifically insulin-like growth factors (IGFs), could help to explain the variability in response to eccentric exercise. Insulin-like growth factors are members of a family of proteins involved in satellite cell differentiation and proliferation. (13, 17) In animal models, IGFs play a key role in growth (32) and have been found to increase in response to degeneration and regeneration, thereby influencing satellite cell activation (2, 3, 13, 24, 26) . Research on pigs has shown that there are quantitative trait loci (QTLs) affecting growth, muscle mass, or fat deposition that map to the IGF-I and IGF-II loci (4, 28, 43) .
Polymorphisms have been identified in the IGF-I and IGF-II genes in humans that are associated with muscle phenotypes. Kostek et al. (20) found that the development of muscular strength in response to a resistance training program was associated with the IGF-I dinucleotide repeat polymorphism located in the promoter region such that carriers for the 192 allele gained significantly more strength than noncarriers of this allele. Two studies reported significant associations of IGF-II ApaI polymorphism and muscle phenotypes. First, Sayer et al. (39) found the ApaI polymorphism of the IGF-II gene was associated with grip strength for men but not women in a large sample of 693 men and women in the United Kingdom. Second, Schrager et al. (40) genotyped subjects for the IGF-II ApaI polymorphism from cohorts of prior studies and tested for associations with arm and leg strength and body composition. For men, arm strength was greater for the homozygous wildtype than the homozygous rare allele group, while for Page 4 of 27 women, the homozygous rare allele group showed lower arm and leg strength and lower total body fat free mass compared with homozygous wildtype.
Exertional muscle damage through eccentric exercise has been found to activate satellite cells (9, 11) . Crameri et al. (9) reported that muscle biopsies taken after subjects performed eccentric exercise showed a significant increase in mononuclear cells staining positive for neural cell adhesion molecule (N-CAM), an abundant protein that had been found on the surface of early embryonic myotubes, and fetal antigen 1 (FA1), indicating activation of satellite cells (38) .
Quiescent satellite cells are likely activated by growth factors, such as IGF-I, released from damaged muscle fibers (18, 25) . Keller et al. (18) found that after contraction-induced damage in murine soleus muscle, there was a significant increase in IGF-I and IGF-II in the days following the injury. Developmental myosin heavy chain staining also increased and was co- A8618T, -C1592A) with indicators of muscle regeneration: strength recovery, muscle soreness, and increases in circulating levels of CK and Mb (see Table 1 for SNP positions and SNP IDs). 
METHODS
The blood samples used in this study were derived from a larger clinical trial and further details are presented in our earlier work (6, 8) . Briefly, in that study, we applied one dosage of a topical NSAID analgesic to the elbow flexors approximately 12-14 hours after the exercise. In the statistical analyses for associations in the current study, treatment was included as a covariate.
We took an additional sample of blood for DNA genotyping. Subjects gave informed consent for this additional sample, and the protocol and informed consent document for both the clinical trial and the additional blood draw were approved by the University of Massachusetts Human Subjects Review Committee. Of the 208 subjects who participated in the clinical trial, 181 subjects agreed to have the additional blood sample taken for DNA testing. Viable DNA samples were isolated from 156 subjects, 78 men and 78 women, but the number of subjects differs for each SNP. Within this study sample, there were approximately 74% Caucasians, 3%
African-Americans, 4% Hispanics, 13% Asians, and 7% who self-classified their race as "other."
We have previously reported data on associations of alpha-actinin 3 (ACTN3) and myosin light chain kinase (MLCK) with markers of muscle damage in this same subject group (6) . Subject inclusion criteria is described in our previous report (6, 8) .
Subjects performed 50 maximal isotonic eccentric (muscle lengthening) contractions of the elbow flexor muscles of their non-dominant arm on a modified preacher curl bench (31) . Details of the exercise can be found in our earlier work (6, 8) . Subjects performed three maximal isometric contractions at an elbow angle of 90 degrees (3 seconds each with one minute between trials) before and immediately after exercise, and the average was used as the criterion measure.
Subjects returned to the laboratory 4, 7, and 10 days post-exercise for assessment of strength and to have a blood sample drawn. Muscle soreness was assessed pre-exercise, 3, 4, 7, and 10 days post-exercise using a visual analog scale, a 100 mm line on which subjects place a mark between 0 (no soreness) to 100 mm (unbearable pain). Blood samples were analyzed for CK activity and myoglobin (Mb) concentration (6) . Another blood sample was drawn in EDTA-containing vacutainer tubes and shipped de-identified to Children's National Medical Center, Washington, D.C. for DNA extraction and subsequent genotyping.
Selection of SNPs and Genotyping
The SNPs for this study were selected based on two criteria: position in the gene and conservation (42) . The methods for genomic DNA extraction and genotyping are previously described (9) . For each SNP, the primers and probes are listed in Table 2 .
Statistics
The phenotypes that were tested for association with genotype were baseline isometric strength To account for any possible effects of sex, body mass and treatment, analyses were conducted in sex-specific cohorts while covarying for body mass, age, and treatment. The percent variation attributable to each SNP was determined with a likelihood-ratio test comparing the full model containing genotype and all covariates to the constrained model containing only covariates.
Data are reported as means ± SEM or adjusted means ± SEM where appropriate. All analyses were performed using Stata Version 8.2 (StataCorp, College Station, TX). We set the significance level at p<0.05, but given that we performed multiple statistical tests, those tests under p<0.01 should be viewed with caution and require validation in future studies.
LINKAGE DISEQUILIBRIUM AND HAPLOTYPES
Pair-wise tests for linkage disequilibrium were done for all 8 polymorphisms within the IGF-II gene region using Lewontin's DR, odds ratio, and R 2 calculation on each pair-wise combination in the 151 subjects from this study cohort (Table 3 and Figure 2 ).
RESULTS
The age, height and body mass of the 151 subjects (78 females and 73 males) from which viable DNA could be isolated were 22.8 ± 4.6 (mean ± SD), 159.2 ± 6.8 cm, and 64. Table 4 shows the genotype and allele frequencies for IGF-I (C1245T), IGF-II SNPS), and IGFBP SNPs.
All SNPs were in Hardy-Weinberg equilibrium. Table 5 presents the significant associations of IGF-II and IGFBP SNPs with changes in CK and strength loss. There were no significant associations of muscle phenotypes with genetic variations in IGF-I. Also, other IGF-II SNPs (G12655A) and IGFBP-3 SNP (A8618T) were not significantly associated with any outcome variable. For men, the IGF-II SNPs G13790C, C16646T, and ApaI were significantly associated with strength, serum CK activity, and soreness. However, for women, fewer significant associations were found.
Men homozygous for the rare allele for IGF-II G13790C showed greater strength loss immediately after exercise, greater soreness at 3 days post, and higher serum CK activity at 7 days post-exercise. Men homozygous for the IGF-II ApaI polymorphism had greater strength loss immediately post-exercise, greater soreness at 4 days post-exercise, and higher serum CK activity at 7 days post-exercise. Men homozygous for the wildtype IGF2AS SNP and G11711T SNP showed greater strength loss and more soreness compared with the heterozygotes. For the G11711T SNP, men homozygous for the wildtype alleles also showed higher CK and Mb response to exercise compared with the heterozygotes.
DISCUSSION
We found the population frequency of the ApaI SNP to be 54.6, 34.4, and 11.0% for GG, GA, and AA, respectively. These values are similar to those previously reported by Schrager et al. Supplemental Table) .
The most significant finding in this study was that for men, IGF-II (G13790C), IGF-II (ApaI), IGF2AS (A1364C), and IGF2AS (G11711T) were significantly associated with muscle damage indicators.
There were fewer significant associations for women. Although there is no apparent explanation for the sex-specific associations, several studies gene association studies also find this to be true.
(5, 37, 47) One reason we did not find a significant association with the IGF-I SNP (-C1245T) or some of the IGF-II SNPs could be that these polymorphisms do not substantially alter the function of the IGF genes; further research is needed to determine whether this is a possibility.
We found a significant correlation of strength loss with serum CK activity at 4 days post exercise (r=-0.43, p<.01) and at 7 days post-exercise (r=-0.50, p<.01). Both the strength loss and increased serum CK activity indicate muscle damage, although strength is considered a better indicator of damage (7, 45) . Men homozygous for the rare allele of IGF-II (G13790C) demonstrated dramatically greater strength loss (58%) immediately post-exercise and serum CK activity at 7 days post-exercise (8818 U/L) compared with the other genotype groups (See Table   5 for the response data for all genotype groups). Likewise, men homozygous for the rare IGF-II ApaI allele demonstrated 60% strength loss immediately post-exercise and 12,261 U/L CK activity at 7 days post-exercise. For the IGF2AS A1364C SNP, men homozygous for the wildtype allele showed the greatest strength loss (58%) and greatest soreness (50 mm). For the C11711T SNP, men homozygous for the wildtype alleles showed greater strength loss (56%) , more soreness (53 mm) and higher increases in blood CK (17,160 U/L) and Mb (659 ng/ml) than one or both other genotype groups. Thus, individuals possessing specific alleles of IGF-II gene appear to be more susceptible to exertional muscle damage. (27) found that IGF-II injected intramuscularly into rabbit extraocular muscles for one week resulted in significantly increased single twitch force and mean tetanic force generation compared to a saline control. In mdx mice, 8 weeks of IGF-I administration by subcutaneous pump was found to improve fatigue resistance (16) and muscle contractile function (force per cross-sectional area) (15) in the diaphragm muscle. After 2 weeks of IGF-I treatment, there was a fourfold increase in serum total IGF-I and no difference in muscle concentration of IGF-I in the treated animals compared with untreated controls (15) .
These data suggest that altered circulating levels of IGFs may influence muscle contractility.
Sayer et al. (39) and O'Dell et al. (33) reported that the mean serum IGF-II concentration in those homozygous for the IGF-II ApaI rare allele was higher than concentrations found for the homozygous wildtype group. However, Roth et al. (40) found that subjects homozygous for the wildtype ApaI allele had 23.7% higher serum IGF-II levels compared to subjects homozygous for the rare allele, but this was not significant. Although not assessed in the current study, it is possible that IGF levels differed by genotype groups, and that such a difference could affect muscle contraction during exercise, possibly by altering calcium handling. Gregorevic et al. (15) suggested that IGF-I administration alters membrane-bound receptor/channel populations that regulate voltage-and ion-dependent calcium release in muscle cells. Thus, skeletal muscle of IGF-II genotype groups may differ in their exposure to circulating IGF-II, which could alter their contractile properties, and explain the significant associations between genotype and muscle damage. Some subjects may be able to generate more force during a contraction and place greater strain on the muscle.
In conclusion, our results show for the first time that specific SNPs in the IGF-II gene are associated with several markers of exertional muscle damage. These results help to explain why some individuals are more susceptible to damage when performing strenuous, unaccustomed exercise and shed light on understanding the rare cases of exertional rhabdomyolysis that have been reported in otherwise healthy people. Skeletal muscle of IGF-II genotype groups may differ in their exposure to circulating IGF-II which could alter calcium handling and force per cross-sectional area during exercise and explain the significant associations between genotype and muscle damage. 
